These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 17016480)

  • 1. A review of work-participation, cost-of-illness and cost-effectiveness studies in ankylosing spondylitis.
    Boonen A
    Nat Clin Pract Rheumatol; 2006 Oct; 2(10):546-53. PubMed ID: 17016480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of ankylosing spondylitis on sick leave, presenteeism and unpaid productivity, and estimation of the societal cost.
    Boonen A; Brinkhuizen T; Landewé R; van der Heijde D; Severens JL
    Ann Rheum Dis; 2010 Jun; 69(6):1123-8. PubMed ID: 20439293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Costs and quality of life of patients with ankylosing spondylitis in Canada.
    Kobelt G; Andlin-Sobocki P; Maksymowych WP
    J Rheumatol; 2006 Feb; 33(2):289-95. PubMed ID: 16465660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review of the costs of illness of ankylosing spondylitis and methodologic notes.
    Boonen A; van der Heijde D
    Expert Rev Pharmacoecon Outcomes Res; 2005 Apr; 5(2):163-81. PubMed ID: 19807572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Large differences in cost of illness and wellbeing between patients with fibromyalgia, chronic low back pain, or ankylosing spondylitis.
    Boonen A; van den Heuvel R; van Tubergen A; Goossens M; Severens JL; van der Heijde D; van der Linden S
    Ann Rheum Dis; 2005 Mar; 64(3):396-402. PubMed ID: 15271773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional disability predicts total costs in patients with ankylosing spondylitis.
    Ward MM
    Arthritis Rheum; 2002 Jan; 46(1):223-31. PubMed ID: 11817595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The burden of ankylosing spondylitis.
    Boonen A; van der Linden SM
    J Rheumatol Suppl; 2006 Sep; 78():4-11. PubMed ID: 17042055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Socioeconomic consequences of ankylosing spondylitis.
    Boonen A
    Clin Exp Rheumatol; 2002; 20(6 Suppl 28):S23-6. PubMed ID: 12463442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Costs and quality of life of patients with ankylosing spondylitis in Hong Kong.
    Zhu TY; Tam LS; Lee VW; Hwang WW; Li TK; Lee KK; Li EK
    Rheumatology (Oxford); 2008 Sep; 47(9):1422-5. PubMed ID: 18635597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost of illness from the public payers' perspective in patients with ankylosing spondylitis in rheumatological care.
    Strömbeck B; Englund M; Bremander A; Jacobsson LT; Kedza L; Kobelt G; Petersson IF
    J Rheumatol; 2010 Nov; 37(11):2348-55. PubMed ID: 20716657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Work status among patients with ankylosing spondylitis in Argentina.
    Marengo MF; Schneeberger EE; Citera G; Cocco JA
    J Clin Rheumatol; 2008 Oct; 14(5):273-7. PubMed ID: 18679137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cost-benefit analysis of [224Ra] radium chloride therapy for ankylosing spondylitis (Bekhterev's disease)].
    Zhang Z; Siegert J; Maywald U; Kirch W
    Med Klin (Munich); 2007 Jul; 102(7):540-9. PubMed ID: 17634872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Costs and quality of life of multiple sclerosis in Switzerland.
    Kobelt G; Berg J; Lindgren P; Gerfin A; Lutz J
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S86-95. PubMed ID: 17310338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perspectives in multiple sclerosis health care: special focus on the costs of multiple sclerosis.
    Rotstein Z; Hazan R; Barak Y; Achiron A
    Autoimmun Rev; 2006 Oct; 5(8):511-6. PubMed ID: 17027884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in economic consequences of rheumatoid arthritis over two subsequent years.
    Verstappen SM; Jacobs JW; Kruize AA; Ehrlich JC; van Albada-Kuipers GA; Verkleij H; Buskens E; Bijlsma JW
    Rheumatology (Oxford); 2007 Jun; 46(6):968-74. PubMed ID: 17337750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Costs and quality of life of multiple sclerosis in Italy.
    Kobelt G; Berg J; Lindgren P; Battaglia M; Lucioni C; Uccelli A
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S45-54. PubMed ID: 17310336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Costs and benefits of an education program for patients with ankylosing spondylitis as part of an inpatient rehabilitation programs-study design and first results].
    Krauth C; Rieger J; Bönisch A; Ehlebracht-König I
    Z Rheumatol; 2003; 62(Suppl 2):II14-6. PubMed ID: 14648082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Costs and quality of life for patients with multiple sclerosis in Belgium.
    Kobelt G
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S24-33. PubMed ID: 17318662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [RAISE study observational and cross sectional study to evaluate the actual reality of the socio-economic impact of ankylosing spondylitis].
    Miranda L; Negreiro F; Queiroz MJ; Silva C
    Acta Reumatol Port; 2008; 33(2):189-97. PubMed ID: 18604185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Costs and quality of life of multiple sclerosis in Austria.
    Kobelt G; Berg J; Lindgren P; Plesnilla C; Baumhackl U; Berger T; Kolleger H; Vass K
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S14-23. PubMed ID: 17310339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.